Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Narjust Duma

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Journal of the National Medical Association|May 18, 2023
Disparities in lung cancerNarjust Duma, Nathaniel Evans, Edith Mitchell
Journal of Women'S Health (2002)|June 24, 2021
Work Patterns of Women Physicians During Vacation: A Cross-Sectional StudyAriela L Marshall, Melissa Elafros, Narjust Duma
JCO Oncology Practice|May 11, 2022
Proyecto ELEVAR: Evaluating the Latinx Experience With the Health Care System Through Variables on Access and ResourcesIdalid Franco, Coral Olazagasti, Fauzia Osman, et al.
BMJ Case Reports|June 12, 2015
Bronchial-oesophageal fistula: a rare initial presentation of squamous cell carcinoma of the lungNarjust Duma, Christian Barlow, Larysa Sanchez, et al.
Mayo Clinic Proceedings|August 6, 2019
Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and TreatmentNarjust Duma, Rafael Santana-Davila, Julian R Molina
Journal of Women'S Health (2002)|April 22, 2021
Videoconferencing Etiquette: Promoting Gender Equity During Virtual MeetingsNatasha Dhawan, Molly Carnes, Angela Byars-Winston, et al.
BMJ Case Reports|September 21, 2019
Primary neuroendocrine carcinoma of the brainClay T Reed, Narjust Duma, Thorvardur Halfdanarson, et al.
Ethnicity & Disease|November 9, 2018
Commentary: Race and Ethnicity in Biomedical Research - Classifications, Challenges, and Future DirectionsDame Idossa, Narjust Duma, Katerina Chekhovskiy, et al.
Clinics and Practice|July 21, 2021
Evidence to Date: Evaluating Pembrolizumab in the Treatment of Extensive-Stage Small-Cell Lung CancerIvy Riano, Shruti R Patel, Stephen V Liu, et al.
Hematological Oncology|March 29, 2016
Safety and tolerability of pomalidomide-based regimens (pomalidomide-carfilzomib-dexamethasone with or without cyclophosphamide) in relapsed/refractory multiple myeloma and severe renal dysfunction: a case seriesJoshua Richter, Noa Biran, Narjust Duma, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Journal of the National Medical Association|May 18, 2023
Disparities in lung cancerNarjust Duma, Nathaniel Evans, Edith Mitchell
Journal of Women'S Health (2002)|June 24, 2021
Work Patterns of Women Physicians During Vacation: A Cross-Sectional StudyAriela L Marshall, Melissa Elafros, Narjust Duma
JCO Oncology Practice|May 11, 2022
Proyecto ELEVAR: Evaluating the Latinx Experience With the Health Care System Through Variables on Access and ResourcesIdalid Franco, Coral Olazagasti, Fauzia Osman, et al.
BMJ Case Reports|June 12, 2015
Bronchial-oesophageal fistula: a rare initial presentation of squamous cell carcinoma of the lungNarjust Duma, Christian Barlow, Larysa Sanchez, et al.
Mayo Clinic Proceedings|August 6, 2019
Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and TreatmentNarjust Duma, Rafael Santana-Davila, Julian R Molina
Journal of Women'S Health (2002)|April 22, 2021
Videoconferencing Etiquette: Promoting Gender Equity During Virtual MeetingsNatasha Dhawan, Molly Carnes, Angela Byars-Winston, et al.
BMJ Case Reports|September 21, 2019
Primary neuroendocrine carcinoma of the brainClay T Reed, Narjust Duma, Thorvardur Halfdanarson, et al.
Ethnicity & Disease|November 9, 2018
Commentary: Race and Ethnicity in Biomedical Research - Classifications, Challenges, and Future DirectionsDame Idossa, Narjust Duma, Katerina Chekhovskiy, et al.
Clinics and Practice|July 21, 2021
Evidence to Date: Evaluating Pembrolizumab in the Treatment of Extensive-Stage Small-Cell Lung CancerIvy Riano, Shruti R Patel, Stephen V Liu, et al.
Hematological Oncology|March 29, 2016
Safety and tolerability of pomalidomide-based regimens (pomalidomide-carfilzomib-dexamethasone with or without cyclophosphamide) in relapsed/refractory multiple myeloma and severe renal dysfunction: a case seriesJoshua Richter, Noa Biran, Narjust Duma, et al.
Pageof 6